Trial of C134 in Patients With Recurrent GBM (C134-HSV-1)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03657576 |
|
Recruitment Status :
Recruiting
First Posted : September 5, 2018
Last Update Posted : March 15, 2024
|
Sponsor:
University of Alabama at Birmingham
Collaborators:
Gateway for Cancer Research
National Cancer Institute (NCI)
Information provided by (Responsible Party):
James Markert, MD, University of Alabama at Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2024 |
| Estimated Study Completion Date : | September 2025 |